FTC opens investigation into Teva, escalating patent fight with pharma industry

[cafead]

via The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers, according to confidential agency documents reviewed by The Washington Post.

article source